Carl E Silver
Overview
Explore the profile of Carl E Silver including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
153
Citations
2911
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodrigo J, Lopez-Alvarez F, Medina J, Silver C, Robbins K, Hamoir M, et al.
Eur J Surg Oncol
. 2024 May;
50(7):108389.
PMID: 38728962
Concomitant chemoradiotherapy (CRT) is extensively used as primary organ preservation treatment for selected advanced laryngeal squamous cell carcinomas (LSCC). The oncologic outcomes of such regimens are comparable to those of...
2.
Matos L, Sanabria A, Robbins K, Halmos G, Strojan P, Ng W, et al.
Adv Ther
. 2023 Mar;
40(5):1957-1974.
PMID: 36920746
The projected increase in life expectancy over the next few decades is expected to result in a rise in age-related diseases, including cancer. Head and neck cancer (HNC) is a...
3.
Cavalheiro B, Shah J, Randolph G, Medina J, Tufano R, Zafereo M, et al.
Cancers (Basel)
. 2023 Feb;
15(3).
PMID: 36765880
Surgery has been historically the preferred primary treatment for patients with well-differentiated thyroid carcinoma and for selected locoregional recurrences. Adjuvant therapy with radioactive iodine is typically recommended for patients with...
4.
Coca-Pelaz A, Rodrigo J, Lopez F, Shah J, Silver C, Al Ghuzlan A, et al.
Expert Rev Anticancer Ther
. 2022 Oct;
22(11):1239-1247.
PMID: 36283091
Introduction: Anaplastic thyroid cancer (ATC) is one of the most lethal diseases known to humans with a median survival of 5 months. The American Thyroid Association (ATA) recently published guidelines...
5.
Medina J, Randolph G, Angelos P, Zafereo M, Tufano R, Kowalski L, et al.
Head Neck
. 2021 Sep;
43(12):3996-4009.
PMID: 34541734
Genetic, symptomatic, and biochemical heterogeneity of patients with primary hyperparathyroidism (PHPT) has become apparent in recent years. An in-depth, evidence-based review of the phenotypes of PHPT was conducted. This review...
6.
Quer M, Hernandez-Prera J, Silver C, Casasayas M, Simo R, Vander Poorten V, et al.
Diagnostics (Basel)
. 2021 Aug;
11(8).
PMID: 34441400
Purpose: To review the current options in the management of Warthin tumors (WTs) and to propose a working management protocol. Methods: A systematic literature search was conducted using PubMed and...
7.
Coca-Pelaz A, Rodrigo J, Shah J, Sanabria A, Al Ghuzlan A, Silver C, et al.
Adv Ther
. 2021 Aug;
38(10):5144-5164.
PMID: 34423400
Introduction: Hürthle cell carcinoma (HCC) comprises about 5% of thyroid carcinoma cases. Partly because of its rarity there is much we still need to know about HCC as compared to...
8.
Vander Poorten V, Meulemans J, Beitler J, Piazza C, Kowalski L, Makitie A, et al.
Eur J Surg Oncol
. 2021 Jun;
47(11):2711-2721.
PMID: 34059377
Nonsurgical primary treatment of early and advanced laryngeal squamous cell carcinoma, employing radiotherapy with or without chemotherapy, is considered a standard of care in many centers throughout the world. When...
9.
Ng W, Tsang R, Beitler J, de Bree R, Coca-Pelaz A, Eisbruch A, et al.
Head Neck
. 2021 Mar;
43(6):1949-1963.
PMID: 33780074
Up to 85% of the patients with nasopharyngeal carcinoma present with regional nodal metastasis. Although excellent nodal control is achieved with radiotherapy, a thorough understanding of the current TNM staging...
10.
Sanabria A, Shah J, Medina J, Olsen K, Robbins K, Silver C, et al.
Cancers (Basel)
. 2020 Apr;
12(4).
PMID: 32344717
Background: Larynx cancer is a common site for tumors of the upper aerodigestive tract. In cases with a clinically negative neck, the indications for an elective neck treatment are still...